Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 101.99M P/E - EPS this Y 45.30% Ern Qtrly Grth -
Income -81.45M Forward P/E -1.16 EPS next Y -0.80% 50D Avg Chg 4.00%
Sales 80.03M PEG 0.31 EPS past 5Y - 200D Avg Chg -11.00%
Dividend N/A Price/Book 0.53 EPS next 5Y -13.70% 52W High Chg -61.00%
Recommedations 2.00 Quick Ratio 2.93 Shares Outstanding 65.94M 52W Low Chg 26.00%
Insider Own 24.10% ROA -23.28% Shares Float 28.85M Beta 1.92
Inst Own 60.13% ROE -56.49% Shares Shorted/Prior 2.27M/1.98M Price 2.18
Gross Margin 27.76% Profit Margin -101.78% Avg. Volume 239,790 Target Price 7.05
Oper. Margin -74.81% Earnings Date Nov 5 Volume 213,449 Change -3.11%
About Personalis, Inc.

Personalis, Inc. develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD) and recurrence in cancer; and ImmunoID NeXT, a tissue-based test that combines whole exome (DNA) and whole transcriptome (RNA) sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample. It also provides NeXT Personal Dx, a tumor-informed liquid biopsy test for detection of MRD and recurrence in cancer; and NeXT Dx, a comprehensive tumor profiling test that unlocks the entire exome (DNA) and transcriptome (RNA) with matched tumor-normal analysis. In addition, the company performs whole exome sequencing (WES) of cancer tissue and matched blood samples for diagnostic companies as an input to their products; and whole genome sequencing (WGS) on human samples for research projects, such as population sequencing initiatives, as well as offers sequencing and data analysis services to support population sequencing initiatives. Its customers include pharmaceutical companies, biopharmaceutical companies, diagnostics companies, universities, non-profits, government entities, and patients. The company was incorporated in 2011 and is headquartered in Fremont, California.

Personalis, Inc. News
PSNL Chatroom

User Image Starlight12 Posted - 57 minutes ago

$PSNL FKG MMS, TUTES WITH THEIR ALGOS playing games. They been fkg killing us here..ass holes

User Image degeneratetrader23 Posted - 5 hours ago

$PSNL broken stock, plain and simple.

User Image Starlight12 Posted - 5 hours ago

$PSNL fkg down 10% everyday.. Fkg joke pos

User Image Starlight12 Posted - 5 hours ago

$PSNL tmr sub 3s Tks fkg manipulating the price algos

User Image degeneratetrader23 Posted - 7 hours ago

$PSNL Matt Gaetz just withdrew. If RFK JR does the same, we should get some desperately needed tail winds.

User Image MrWick007 Posted - 7 hours ago

$PSNL why dead??

User Image arribaStocktrading Posted - 9 hours ago

$PSNL Volume tells the story of how manipulated this is. Market Makers are in a bid dropping frenzy. I'm buying:

User Image Starlight12 Posted - 9 hours ago

$PSNL kathy was here. Fkg...black cat Cramer effect 🖕🖕 mms, tutes, algos, blackdock funds

User Image degeneratetrader23 Posted - 9 hours ago

$PSNL I think 3.29 is the bottom but there's no catalyst in the near-future.

User Image alexvirdee Posted - 10 hours ago

$PSNL Getting another 300 shares since we're on sale

User Image arribaStocktrading Posted - 11 hours ago

$PSNL 1,162 shares traded in the Pre-Market. Could only mean that someone knows something. My suspicion is that what they know is that this stock is a really good buy at this price and they are not passing on this Doorbuster Sale opportunity.

User Image ExNoose Posted - 16 hours ago

$PSNL Also weekly 50 EMA.

User Image ExNoose Posted - 16 hours ago

$PSNL 200 daily EMA and 0.618 retracement from the lows. Lets see if we hold here.

User Image DC729 Posted - 1 day ago

@BlackMyth basically they issued warrants that converted shares to create sales network / partnership with $TEM (that now owns a majority)that sell and distribute the Company’s cancer tests and also provide a royalty on $PSNL data. $PSNL has leading tech but is waiting on insurance reimbursement for lung and breast cancers, and immunotherapy applications. Once they have approval this partnership provides them with a significant and key turn channel to drive sales growth.

User Image BlackMyth Posted - 1 day ago

$PSNL Why is this company diluting like crazy: OS was 53 mils shares only a few months ago, and now OS is 70 mils !!!

User Image Wax_Bean_futures Posted - 1 day ago

$PSNL

User Image Wax_Bean_futures Posted - 1 day ago

$PSNL getting painful. oh well, puffed rice for dinner for me for a while lol.

User Image arribaStocktrading Posted - 1 day ago

$PSNL "Loss from operations for the third quarter of 2024 was $39.3 million" That's Natera

User Image arribaStocktrading Posted - 1 day ago

$PSNL Natera is now trading for 15x Sales PSNL is trading for less than 3x Sales.

User Image Starlight12 Posted - 1 day ago

$PSNL wow....even worse

User Image alexvirdee Posted - 1 day ago

$PSNL Looking like 3.04 would be next support level. Shame this is going down so much

User Image Starlight12 Posted - 1 day ago

$PSNL fkg rise already. Didnt Cathy Wood buy? Maybe she has "Cramer" effect on stocks Fkg games 50% drop just recently Get this shit back up to 6s

User Image arribaStocktrading Posted - 1 day ago

$PSNL Another day of 70% of all stocks are lower. Such a raging bull market this is. But look at the chart of the Giant Vampire Squid. It's like they knew everything the market would do before it happened!

User Image Wax_Bean_futures Posted - 1 day ago

$PSNL 50% drop from our spike over $7 last August.

User Image Starlight12 Posted - 1 day ago

$PSNL fkg sick. Getting pretty old FKG MMS TUTES, BLACKDOCK, dei algo manipulation Killing retail blood money

User Image Starlight12 Posted - 1 day ago

$PSNL we finally did..after drropping $2 bc of tute games We up 4% premarket with 794 shares exchanged. Boon we did it🤣

User Image arribaStocktrading Posted - 1 day ago

$PSNL Looks like the Goldman Sachs manufactured drop of all-things pharma has about run its course. Always look at the volume. If it's heavy volume, then if it is sell-driven. But if it's just bid-dropping, then it's Goldman Sachs hard at work to steal you blind. How scary is this guy really?

User Image degeneratetrader23 Posted - 2 days ago

$PSNL Xbi hit 30 on the rsi yesterday.

User Image Starlight12 Posted - 2 days ago

$PSNL dump time..fk

User Image Starlight12 Posted - 2 days ago

$PSNL we fkd again

Analyst Ratings
HC Wainwright & Co. Buy Aug 19, 24
BTIG Buy Aug 16, 24
Needham Buy Aug 16, 24
Needham Buy Jun 21, 24
Needham Buy May 9, 24
Lake Street Buy Apr 30, 24
Needham Buy Apr 11, 24
Needham Buy Feb 29, 24
Needham Buy Jan 5, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Chen Richard Chief Medical Office.. Chief Medical Officer and EVP Dec 15 Sell 1.47 4,708 6,921 129,396 12/19/23
Tachibana Aaron CFO and COO CFO and COO Dec 15 Sell 1.47 6,747 9,918 185,237 12/19/23
Moore Stephen Michael General Counsel General Counsel Dec 15 Sell 1.47 1,476 2,170 76,920 12/19/23
Moore Stephen Michael General Counsel General Counsel Nov 16 Sell 1.04 1,722 1,791 78,396 11/20/23
Tachibana Aaron CFO and COO CFO and COO Nov 16 Sell 1.04 1,344 1,398 191,984 11/20/23
Chen Richard Chief Medical Office.. Chief Medical Officer and EVP Nov 16 Sell 1.04 940 978 124,104 11/20/23
Hall Christopher M President and CEO President and CEO Nov 01 Sell 0.93 20,459 19,027 204,541 11/03/23
Chen Richard Chief Medical Office.. Chief Medical Officer and EVP May 17 Sell 1.98 971 1,923 130,346 05/19/23
Tachibana Aaron CFO and COO CFO and COO Mar 17 Sell 2.83 3,945 11,164 202,283 03/21/23
Chen Richard Chief Medical Office.. Chief Medical Officer and EVP Mar 17 Sell 2.83 1,314 3,719 131,317 03/21/23
Tachibana Aaron Chief Financial Offi.. Chief Financial Officer Jan 31 Sell 2.20 767 1,687 206,228 02/02/23
Tachibana Aaron Chief Financial Offi.. Chief Financial Officer Dec 02 Sell 2.60 4,360 11,336 218,015 12/06/22
Chen Richard Chief Medical Office.. Chief Medical Officer Dec 02 Sell 2.60 440 1,144 142,120 12/06/22
Moore Stephen Michael General Counsel General Counsel Nov 16 Sell 2.71 2,045 5,542 90,440 11/18/22
Tachibana Aaron Chief Financial Offi.. Chief Financial Officer Nov 16 Sell 2.71 1,294 3,507 222,375 11/18/22
Chen Richard Chief Medical Office.. Chief Medical Officer Sep 20 Sell 3.48 1,581 5,502 143,855 09/22/22
Tachibana Aaron Chief Financial Offi.. Chief Financial Officer Sep 20 Sell 3.48 3,474 12,090 223,669 09/22/22
Chen Richard Chief Medical Office.. Chief Medical Officer Sep 02 Sell 3.33 420 1,399 145,436 09/08/22
Chen Richard Chief Medical Office.. Chief Medical Officer Jul 28 Sell 3.91 632 2,471 145,856 08/01/22
Tachibana Aaron Chief Financial Offi.. Chief Financial Officer Jul 28 Sell 3.91 632 2,471 231,311 08/01/22
Chen Richard Chief Medical Office.. Chief Medical Officer Jun 17 Sell 3.29 1,565 5,149 146,488 06/21/22
Tachibana Aaron Chief Financial Offi.. Chief Financial Officer Jun 17 Sell 3.29 3,440 11,318 231,943 06/21/22
Moore Stephen Michael General Counsel General Counsel Jun 15 Sell 3.24 1,832 5,936 73,885 06/17/22
Tachibana Aaron Chief Financial Offi.. Chief Financial Officer Jun 15 Sell 3.24 6,818 22,090 235,383 06/17/22
Tachibana Aaron Chief Financial Offi.. Chief Financial Officer Jun 02 Sell 3.59 4,187 15,031 242,201 06/06/22
Chen Richard Chief Medical Office.. Chief Medical Officer Jun 02 Sell 3.59 421 1,511 154,871 06/06/22
Tachibana Aaron Chief Financial Offi.. Chief Financial Officer May 16 Sell 4.86 1,286 6,250 246,388 05/18/22
West John Stephen President and CEO President and CEO May 16 Sell 4.86 2,408 11,703 382,444 05/18/22
Moore Stephen Michael General Counsel General Counsel May 16 Sell 4.86 664 3,227 75,717 05/18/22
Chen Richard Chief Medical Office.. Chief Medical Officer May 16 Sell 4.86 1,286 6,250 155,830 05/18/22
Moore Stephen Michael General Counsel General Counsel May 02 Sell 5.53 5,733 31,703 76,381 05/04/22
West John Stephen President and CEO President and CEO Apr 20 Option 1.84 45,061 82,912 384,852 04/22/22
West John Stephen President and CEO President and CEO Apr 13 Option 1.84 64,430 118,551 404,221 04/15/22
Lightspeed Venture Partners Se... Other Other Mar 02 Buy 10.06 314,750 3,166,385 4,750 03/04/22
Chen Richard Chief Medical Office.. Chief Medical Officer Mar 02 Sell 10.18 471 4,795 157,334 03/04/22
Tachibana Aaron Chief Financial Offi.. Chief Financial Officer Mar 02 Sell 10.18 4,511 45,922 251,441 03/04/22
Chen Richard Chief Medical Office.. Chief Medical Officer Jan 28 Sell 9.93 705 7,001 157,805 02/01/22
Tachibana Aaron Chief Financial Offi.. Chief Financial Officer Jan 28 Sell 9.93 705 7,001 255,952 02/01/22
West John Stephen President and CEO President and CEO Jan 18 Sell 11.37 99,987 1,136,852 285,457 01/19/22
West John Stephen President and CEO President and CEO Jul 12 Sell 22.54 110,000 2,479,400 635,520 07/12/21
West John Stephen President and CEO President and CEO Jun 10 Sell 22.66 110,000 2,492,600 560,520 06/10/21
Chen Richard Chief Scientific Off.. Chief Scientific Officer Dec 03 Option 0.44 40,000 17,600 152,750 12/03/20
Chen Richard Chief Scientific Off.. Chief Scientific Officer Dec 03 Sell 27.88 40,293 1,123,369 112,457 12/03/20
Abingworth LLP 10% Owner 10% Owner Oct 14 Sell 28.76 202,360 5,819,874 4,260,092 10/14/20
Chen Richard Chief Scientific Off.. Chief Scientific Officer Oct 05 Option 0.44 37,452 16,479 152,750 10/05/20
Chen Richard Chief Scientific Off.. Chief Scientific Officer Oct 05 Sell 21.97 40,000 878,800 112,750 10/05/20